Table 1 Baseline patient characteristics by NLR and SII status.
Patient characteristics | NLR | p | SII | p | ||
|---|---|---|---|---|---|---|
< 3 | ≥ 3 | < 730 | ≥ 730 | |||
No. (%) | No. (%) | No. (%) | No. (%) | |||
Median age, years [range] | 60 [19–83] | 64 [32–85] | 0.066 | 58 [31–83] | 64 [19–85] | 0.012 |
Performance Status (ECOG) | ||||||
0 | 147 (68.7) | 79 (51.3) | 0.0007 | 111 (73.5) | 115 (53.0) | < 0.0001 |
1–2 | 67 (31.3) | 75 (48.7) | 40 (26.5) | 102 (47.0) | ||
EOC histology | ||||||
Other | 65 (29.5) | 49 (31.6) | 0.669 | 51 (32.7) | 63 (28.8) | 0.416 |
Serous | 155 (70.5) | 106 (68.4) | 105 (67.3) | 156 (71.2) | ||
Stage | ||||||
III | 163 (74.1) | 102 (65.8) | 0.083 | 118 (75.6) | 147 (67.1) | 0.074 |
IV | 57 (25.9) | 53 (34.2) | 38 (24.4) | 72 (32.9) | ||
Ascites | ||||||
No | 113 (53.0) | 66 (42.6) | 0.047 | 83 (54.2) | 96 (44.6) | 0.070 |
Yes | 100 (47.0) | 89 (57.4) | 70 (47.8) | 119 (55.4) | ||
BRCA status | ||||||
Wild type | 42 (63.6) | 21 (80.8) | 0.113 | 31 (63.3) | 32 (74.4) | 0.253 |
Mutated | 24 (36.4) | 5 (19.2) | 18 (36.7) | 11 (25.6) | ||
Unknown | 154 | 129 | 107 | 176 | ||
Treatment | ||||||
CT | 181 (82.3) | 120 (77.4) | 124 (79.5) | 177 (80.8) | ||
CTB | 39 (17.7) | 35 (22.6) | 0.245 | 32 (20.5) | 42 (19.2) | 0.749 |
